Medication Administration Program (MAP) Recent News

The purpose of this advisory is to provide clarification and guidance applicable to the administration of medications to children residing at Approved Private Special Education School Residential Programs (ASERPs) jointly approved and licensed by the Department of Elementary and Secondary Education (DESE) and the Department of Early Education and Care (DEEC). This guidance does not apply to other types of residential or boarding schools.

• Medication Administration in Private Approved Special Education School Residential Programs (PDF) | (DOCX)

Presentation slides from the March 7, 2024

• Quarterly MAP Stakeholder Workgroup Meeting 3/7/2024 (PPTX)

A new version of the MAP Policy Manual (11/15/2023), along with a guide to the updates and changes, has been posted here

• MAP Policy Manual (3/1/2024)
• Guide to the MAP Policy Manual (3/1/2024)

A new version of the MAP Policy Manual (11/15/2023), along with a guide to the updates and changes, has been posted here. 

• MAP Workgroup Presentation 11/16/2023 (PPTX)
  • This PowerPoint Presentation provides an overview of the changes to MAP policy adopted over the past six months and a look forward at continuing efforts to modernize the program.

Alternate compliance method for MAP Advisory “Prepackaged Medication Administration by Non-MAP Certified staff” issued 8/1/23

Effective immediately, DCP will accept an alternate compliance method for MAP Advisory issued 8/1/23 ‘Prepackaged Medication Administration by Non-MAP Certified staff in Registered Community Programs’ . If a MAP Registered site utilizes pharmacy prepared multi-dose packaged medications, the MAP Certified Supervisor or their MAP Certified designee, may utilized these pre-packaged medications in keeping with the 8/1/23 guidance. If there are additional HCP ordered medications to be packed that are not included in the pharmacy prepared multi-dose medication ‘packets’ (e.g., a countable controlled medication, etc.), the MAP Certified Supervisor or their MAP Certified designee will follow the guidance to package the medication. The pharmacy prepared multi-dose packaged medications and the medication packaged by the MAP Certified Supervisor or their MAP Certified designee, for the same individual on the same date and time for administration, must be fastened together (e.g., the two packets could be stapled together).

Please be reminded that with the addition above, all guidance requirements must be followed including weekly reporting. 

This alternative compliance method will remain in effect until 11/10/23

A revised MAP Policy Manual and a Guide to this new version has been posted MAP Policy Manual | Mass.gov.  This new version is reorganized and contains several important policy changes. We encourage you to read through the Guide to identify these changes.

• Prepackaged Medication Administration by Non-MAP Certified staff in Registered Community Programs (PDF) | (DOCX)

• Circular Letter: DCP 23-04-119

• Map Site Document Retention Advisory (PDF) | (DOC)

• Valid Health Care Provider Orders – Prescriber Signature (PDF) | (DOCX)
• MAP Policy on Transcription Training and Testing (PDF) | (DOCX)

• Order of the Commissioner of Public Health (COVID-19 Public Health Emergency Order No. 2022-20) 
  • Prepackaged Medication Administration by Non-MAP Certified staff in Registered Community Programs – Guidance 
• Order of the Commissioner of Public Health COVID-19 Public Health Emergency Order No. 2022-22 
  • Use of Rescue Inhalers and Epinephrine Autoinjectors in Community Programs - Guidance 

• MAP Evaluation Report 2022 (PDF)
• MAP Evaluation Report 2022 (DOCX)
• MAP Evaluation Report 2022 Summary (PPT)

• Order of the Commissioner of Public Health (COVID-19 Public Health Emergency Order No. 2022-20)

• Revised Medication Occurrence Report: Section 9 Medication Occurrence Report (MOR) | (DOCX)

• Order of the Commissioner of Public Health COVID-19 Public Health Emergency Order No. 2022-20

• Order of the Commissioner of Public Health (COVID-19 Public Health Emergency Order No. 2022-17) allowing certain staff to possess and administer prepacked medications in those community programs registered with the Department of Public Health’s Medication Administration Program (issued June 27, 2022)
• Order of the Commissioner of Public Health (COVID-19 Public Health Emergency Order No. 2022-16) regarding use of rescue inhalers and epinephrine autoinjectors in community programs (issued June 27, 2022)
  • Access to Rescue Inhalers and Epinephrine Auto-Injectors in Community Programs
• COVID-19 – Reinstatement of Expired/Lapsed MAP Certifications
• COVID-19 – Insulin Pen Administration by MAP Certified Staff via Telehealth
• COVID-19 – LOA Medication Supply Expansion – extension

• Order of the Commissioner of Public Health COVID-19 Public Health Emergency Order No. 2022-13 | (DOCX)

Methadone – Storage and Administration of Take-Home Doses (PDF) | (DOC)

• Order of the Commissioner of Public Health (COVID-19 Public Health Emergency Order No. 2021-15)
• COVID-19 – Insulin Pen Administration by MAP Certified Staff via Telehealth
• COVID-19 – LOA Medication Supply Expansion – Extension
• Access to Rescue Inhalers and Epinephrine Auto-Injectors in Community Programs (Updated)
• COVID-19 – Reinstatement of Expired/Lapsed MAP Certifications

• Order of the Commissioner of Public Health (COVID-19 Public Health Emergency Order No. 2021-8)
• Access to Rescue Inhalers and Epinephrine Auto-Injectors in Community Programs | (DOCX)
• COVID-19 – Insulin Pen Administration by MAP Certified Staff via Telehealth | (DOCX)
• MAP Virtual Two-Person Count and Disposal of Countable Controlled Substances – Waiver Notice | (DOCX)
• MAP Virtual Two-Person Count and Disposal of Countable Controlled Substances – Waiver Form | (DOCX)
• OTC Method B – Remote verification by licensed professionals – Waiver Notice | (DOCX)
• OTC Method B – Remote verification by licensed professionals – Waiver Form | (DOCX)
• COVID-19 – LOA Medication Supply Expansion – extension | (DOCX)

• Section 9 Medication Occurrence Report (MOR) l (DOCX)
• MAP MCSR Application Form (New and Renewal) l (DOCX)
• Guide to Completing the MAP MCSR Application Form l (DOCX)

• MAP – Rescue Inhalers, Epinephrine Auto-Injectors and Oxygen in Community Programs
• MAP – Virtual Two-Person Count and Disposal of Countable Controlled Substances
• MAP – OTC Method B – Remote verification by licensed HCP
• MAP – Leave of Absence Medication Supply Expansion
• MAP – Insulin Pen Admin by MAP Certified Staff via Telehealth
• MAP – Rescission of Extension Order for MAP Certified Staff

MAP Policy Manual

• Section 9 Medication Occurrence Report (MOR)

MAP Policy 10-3 Controlled Substance Count

MAP Policy No. 01-2 Criteria for Site Registration with DPH

COVID-19 - Reinstatement of MAP Certification (with Attestation)

3-26-2020 COVID-19 MAP Certification Extension

3-20-2020 COVID-19 Valid HCP Signature

3-16-2020 COVID-19 – LOA Medication Supply Exception

Medication Administration in Private Approved Special Education School Residential Programs

On the MAP Resources Page: https://www.mass.gov/lists/map-resources 

• Link added: Valid Health Care Provider Orders - MAP Sites  (PDF) 

On the MAP Resources Page: https://www.mass.gov/lists/map-resources

• Link added: Notice of Rescission of MAP High Alert Medication (Combination drug product buprenorphine hydrochloride and naloxone (brand name Suboxone) Policy 08-7

On MAP Policy Manual: https://www.mass.gov/lists/map-policy-manual